Published by FACT MR
Posted on September 20, 2021
8 min readLast updated: February 5, 2026
The Interphalangeal Fusion market is growing due to increased arthritis and hammertoe cases, with significant potential in Asia Pacific.
A newly compiled research report by Fact.MR offers valuable perspectives on the Interphalangeal Fusion market Sales and detailed insights pertaining to its demand & growth prospects over the forecast period, 2018 to 2028
This study offers an overview of existing market trends, metrics, drivers, and restrictions and offers a point of view for important segments. The report mentions growth parameters in the regional markets along with major players dominating the regional growth.
Interphalangeal fusion or arthrodesis is a surgical technique for immobilizing the distal or proximal joints of hands or legs for the treatment of pain, deformity, or instability of the joint resulting from degenerative, inflammatory, or posttraumatic disorders such as hammertoe and arthritis.
To Remain ‘Ahead’ Of Your Competitors, Request for Brochure – https://www.factmr.com/connectus/sample?flag=B&rep_id=1346
The report Gives brief overview of Interphalangeal Fusion market outlook & Size, about the current market landscape, trends, major Key players, product type, application, and region. It also includes the impact of COVID-19 on the global Interphalangeal Fusion market Sales & demand, future forecasts, growth opportunities, end-user industries..
The report covers following Interphalangeal Fusion Market insights and assessment that are helpful for all participants involved in the Interphalangeal Fusion market:
Competitive Landscape Analysis on Interphalangeal Fusion Market:
To provide decision-makers with credible insights on their competitive landscape, the Interphalangeal Fusion industry research report includes detailed market competitive landscape analysis.
Many stakeholders are consistently adopting new methodologies to boost growth of Interphalangeal Fusion market. Few investors are investing on research and development of new products, on the other hand, various companies are innovating the existing products.
Examples of some of the major players operating in the global interphalangeal fusion market are Arthrex, Inc., Biomet, Inc., Acumed, Nextremity Solutions, Inc., Arthrosurface, Arrowhead Medical Device Technologies, Wright Medical Group N.V., Centric Medical LLC. (Life Spine, Inc.), Lineage Medical, Inc., BioPro implants, Instratek, Stryker, Extremity Medical LLC and others.
Enquiry Before Buying – https://www.factmr.com/connectus/sample?flag=EB&rep_id=1346
Some of the common segments mentioned in the report include market overview, tends, drivers, opportunities, restraints, regional segment, end-use application, and competitive landscape.
The global market for interphalangeal fusion is highly consolidated with a handful players dominating the scene. The interphalangeal fusion market shows a definite shift in favor of the developing regions of Asia Pacific, such as India and China.
There is also a strong trend of collaboration between large hospitals and third party payers, owing to distribution efficiency and strategic partnerships. Technology gains from product development represent largest value proposition over cost.
For example, BioPro implants developed the Osteotec Silicone Finger Implant using high tear resistant implant grade silicone, replacing the traditional cobalt chromium metals. Companies are also developing titanium metal implants for patients suffering from metal allergies related to standard cobalt chrome.
Product development is another attractive strategy followed by many companies. For example, Centric Medical announced the FDA clearance of the metatarsal hemi implant system in February 14, 2017, followed by the FDA 510(k) clearance of its cannulated screw internal fixation system in January 18, 2018.
The global interphalangeal fusion market can be segmented on the basis of the device, end user and region.
Based on the device, the global interphalangeal fusion market has been segmented into:
Based on the material of construction, the global interphalangeal fusion market has been segmented into:
Based on the end user, the global interphalangeal fusion market has been segmented into:
The analysis also sheds light on the impact of various government initiatives undertaken across the globe on the Interphalangeal Fusion market Demand.
Why to purchase this Report?
Following are the reasons to consider this Interphalangeal Fusion Market report By Fact.MR – a market research and competitive intelligence provider:
The global interphalangeal fusion market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa.
North America, dominated by the U.S., accounts for the largest share in the global interphalangeal fusion market, owing to the concentration of key market players, increasing number of large procedures, rising awareness and faster uptake of latest technologies.
The Europe interphalangeal fusion market is expected to be led by Germany, France and the U.K. The advanced medical devices industry in Germany is a significant driver for the European market.
The Asia Pacific excluding Japan interphalangeal fusion market is expected to grow at the fastest CAGR, owing to the growing healthcare expenditure and improvements in healthcare infrastructure with China and India expected to hold the lion’s share.
The Middle East and Africa interphalangeal fusion market is expected to be dominated by wealthy gulf economies of Saudi Arabia, Kuwait, UAE and Qatar.
The development of healthcare infrastructure, owing to government initiatives, coupled with large public healthcare expenditure, is expected to drive the market for interphalangeal fusion in the Middle East and Africa region.
Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=1346
The rising incidence rate of hammertoe and arthritis is the prime driver of the market growth. According to the Center for Disease Control, an estimated 54.4 Million U.S. adults suffer from arthritis, rheumatoid arthritis, gout, lupus or fibromyalgia annually. CDC further predicts that an estimated 78 Million U.S. adults will suffer from arthritis by 2040.
The percentage of the older population, aging 65 years or older, suffering from arthritis is a staggering 49.6% with osteoarthritis being the most common form, affecting an estimated 31 Million Americans per year.
According to the National Foot Health Assessment about 3% of U.S. adults aged 21 and older, reflecting approximately 7 Million people, suffered from hammertoe in 2015. Thus, a large and sustainable market exists in the region, which is easily comprehendible.
Technological developments such as the development of lightweight and strong fixation implants made of titanium and other materials, customization of implant screws according to patient sizes and others are driving larger market uptake.
The high cost of surgery and lack of awareness are some of the restraints in the global interphalangeal fusion market. Surgical complications such as risk of infection and pain, coupled with the poor healthcare infrastructure in developing regions, are other constraints that impede the growth of the interphalangeal fusion market. The market also suffers from competition from external fixation as well as shoe inserts, which may hamper the growth of the market.
Read More Trending Reports of Fact.MR : https://www.biospace.com/article/future-pediatric-neuroblastoma-treatment-will-center-around-new-product-development-study/
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
The post Rising Incidence Of Hammertoe And Arthritis Is Prime Driver For Interphalangeal Fusion Market demand appeared first on The Cloud Tribune.
The article discusses the growth of the Interphalangeal Fusion market driven by conditions like hammertoe and arthritis.
Major players include Arthrex, Biomet, Acumed, and Stryker.
Significant growth is noted in Asia Pacific, particularly in India and China.
Explore more articles in the Research Reports category
